• Baked In
  • Posts
  • 🇺🇸 These 5 States Just Redrew the Cannabis Map Overnight

🇺🇸 These 5 States Just Redrew the Cannabis Map Overnight

Good morning, loyal readers —

November’s elections opened real doors for cannabis reform in places that once looked locked shut. New majorities, newly elected leaders, and shifting political incentives are creating momentum in Texas, Wisconsin, New Hampshire, Nebraska, and Indiana — five states whose 2027 sessions now carry more weight than any recent federal announcement. Public support is already high, neighboring legal markets are waiting, and the question is no longer whether these states will move, but how far and how fast.

Scroll down for our full analysis…

Own Your Edge. TDR subscribers that are new customers get 15% off: https://frepouch.com/discount/DALES

💸 The Tape

The November results redrew the cannabis map faster than any federal action has, and the five states where the ground shifted most are the ones that matter for 2027. Here’s where each stands.

Texas: the biggest prize, with a Senate still in the way

Texas elected a Democratic governor, lieutenant governor and U.S. senator in one night, and all three ran on some version of cannabis reform. Governor-elect Gina Hinojosa wants a referendum on legalization, which requires the legislature to put a constitutional amendment on the ballot. Lt. Governor-elect Vikki Goodwin has been explicit that she favors regulation over prohibition on hemp THC and has accused outgoing Lt. Gov. Dan Patrick of pushing the 2025 hemp ban to benefit alcohol-industry donors. Senator-elect James Talarico says he wants to work with the Trump administration on federal legalization.

The constraint is the chamber Goodwin will preside over. Democrats flipped the Texas House, but Republicans retain the Senate, and no Texas cannabis bill has ever cleared it. What’s changed is that the gavel, the calendar and the committee assignments now belong to someone who wants bills heard rather than buried. Rep. Wes Virdell, a Republican, told reporters cannabis is an issue where he and Democrats “can align,” criticized felony penalties for THC products and predicted “very bipartisan bills” from the House. Realistic 2027 outcomes when the session opens January 12: a statutory hemp THC framework replacing the DSHS rules now being challenged in court, a further expansion of the Compassionate Use Program past the 135,000-patient mark, and a serious floor debate on decriminalization. Full legalization through a referendum needs two-thirds of both chambers, which the Senate math doesn’t support yet.

Wisconsin: the trifecta that changes everything

Wisconsin is the cleanest story on the board. Democrats won the governorship with David Crowley, flipped the Senate to 18-15 and took the Assembly 53-46. Wisconsin has no citizen initiative process, so legalization has always required the legislature, and the Republican majority killed every attempt including Senate Bill 1045 earlier this year. That barrier is gone. Crowley has tied legalization directly to offsetting federal Medicaid cuts, the incoming Assembly speaker has called it a priority, and public support sits at 67% in Marquette polling. The question for 2027 isn’t whether Wisconsin passes a bill but what kind: medical-first with an adult-use trigger, or a full program modeled on Minnesota or Michigan. Either way, Wisconsin becomes the first state to legalize purely through a legislature flipped in a single election, and it borders Illinois, Michigan and Minnesota, all of which have been collecting Wisconsin residents’ cannabis tax dollars for years.

New Hampshire: a legislature that can pass it and a governor who will veto it

Democrats took both chambers in Concord, including a House supermajority, and Rep. Jared Sullivan is drafting a bill that would legalize possession, allow private state-licensed retail and permit sales through the state liquor system, taxed under the meals and rooms tax. Timothy Egan, one of the legislature’s most vocal legalization advocates, won his seat back and said flatly, “That’s why I ran.” House Bill 186 already passed the House 208-135 in January before the Republican Senate tabled it.

The obstacle is Governor Kelly Ayotte, who won re-election and has vowed to veto any legalization bill. Override requires two-thirds in both chambers. Democrats have the House. In the 24-seat Senate they hold roughly 15 and need 16, so the bill lives or dies on a single Republican senator. A few Senate Republicans have voted for legalization before, but voting to override your own party’s governor is a different act. Expect a bill to pass both chambers in the spring and a veto fight that comes down to one vote. New Hampshire is the last New England state without legal sales, and 70% of its residents want them.

Nebraska: medical cannabis exists on paper, not on shelves

Nebraska didn’t flip anything in November, but it’s on this list because voters approved medical cannabis two years ago and still can’t buy any. The Nebraska Supreme Court upheld the 2024 initiatives in September, ending the signature-sufficiency challenge. The Medical Cannabis Commission has licensed four cultivators, capped dispensaries at 12 and flowering plants at 1,250, and this week forwarded fee regulations to Attorney General Mike Hilgers for constitutional review without the changes licensees requested. Hilgers has opposed the program at every turn. The commission also lacks statutory authority to let in-state labs test product, which means even a licensed cultivator can’t legally sell. The session opens January 6, and the fix requires the legislature to act on testing authority and licensing caps. One senator has signaled a 2027 recreational legalization bill citing tax revenue, but the realistic 2027 story is whether the Unicameral finally lets the medical program its voters approved actually function.

Indiana: the Republican state that’s starting to move

Indiana remains a GOP trifecta, but the posture has changed. Governor Mike Braun has gone from “agnostic” to saying the state is “more likely” to legalize now that federal rescheduling is underway and will “probably have to address” it. Sen. Mike Bohacek, a Republican, is filing a medical-only bill for 2027 with impairment thresholds, law enforcement training and healthcare-supervised distribution. And Secretary of State-elect Beau Bayh, the lone Democrat to win statewide, wants a constitutional amendment allowing citizen ballot initiatives so voters can decide directly. Ball State polling shows 84% support for medical access. The obstacle is legislative leadership: Senate President Pro Tem Rodric Bray and Speaker Todd Huston have both opposed even medical legalization, and U.S. Sen. Jim Banks has urged Braun to hold the line. Indiana won’t legalize in 2027. But a Republican governor, a Republican sponsor and a Democratic Secretary of State pushing from three directions is the most movement the state has seen in a decade.

The common thread

Four of these five states border legal markets and watch their residents drive across the line. All five have public support above 60%. What changed in November is that in Wisconsin the votes now exist, in Texas and New Hampshire the leadership does, in Indiana the governor has stopped saying no, and in Nebraska the courts have run out of reasons to delay. The 2027 sessions will show which of those is enough.

📈 Dog Walkers

$DBCCF Reports Q3

Decibel reported Q3 revenue of C$35.1 million, up 7%, and reaffirmed full-year guidance of C$132 to 137 million in net revenue and C$28 to 32 million in adjusted EBITDA. Alongside it, Shawn Dym and Benjamin Sze published a first-ever quarterly shareholder letter titled “How We Feel,” which the company says is deliberately not a results summary. The results summary is interesting enough on its own.

The story is the split. International sales hit a record C$12.1 million, up 44% year over year and 14% sequentially, the third straight record quarter. Nine-month international revenue of C$32.3 million has already passed all of 2025. Meanwhile Canadian net recreational sales fell 6% to C$23.0 million, and nine-month domestic growth is just 2%. Decibel is now a company where a third of revenue comes from EU-GMP exports growing at 44%, and two-thirds comes from a home market going backward.

That mix is why margins expanded even as domestic shrank. Gross margin rose 500 basis points to 52%, and the company swung to net income of C$3.8 million from a C$1.3 million loss. Adjusted EBITDA of C$7.4 million was up only 2%, which tells you the export margin gain is being partly absorbed by higher finance costs following the debt refinancing.

The gaps: operating cash flow of C$1.2 million in the quarter and negative C$7.6 million year-to-date, which the company attributes to a one-time C$17.8 million receivables build and payables unwind tied to the refinancing. International customers pay slower than Canadian provincial boards, and that working-capital drag is structural to the export model, not a one-quarter event. No cash or debt figures appear in the release.

What’s working: 60 tons of Chatham flower capacity at only 42% utilization, 20-plus international customers under contract, three new markets expected within six months, and the first UK shipment to Hilltop Leaf in progress. Sze says Decibel will “enter 2027 from a position of strength.” The export numbers back him. The Canadian ones are why Ewing Morris could buy 6.8% of the company at C$1.91.


🗞️ The News

📺 Trade To Black

Our D.C. Takeaways: Hemp Ban, Rescheduling and Banking | TTB Presented by Flowhub

  • FinCEN proposes streamlining customer due diligence: the November 16 proposal would codify relief so an existing bank customer opening a new account doesn’t trigger fresh beneficial-ownership verification. For cannabis operators juggling multiple accounts, that’s less paperwork.

  • The catch: it’s a general rule that doesn’t touch FinCEN’s 2014 marijuana guidance, so banks still have to verify state licenses, monitor activity and file suspicious activity reports on every cannabis client.

  • The GAO’s August report found compliance cost and regulatory risk still keep banks away, with roughly 1,000 institutions filing marijuana-related SARs in 2024, a number that overstates how many actively serve the industry.

  • Shadd explains why FinCEN and the DEA are working inside the existing framework rather than rewriting it, what full rescheduling would change, and why SAFE Banking remains a separate fight in Congress. Public comment runs 60 days from publication.